Norway Influenza Vaccine Market Size & Outlook, 2024-2030

Name: Norway Influenza Vaccine Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The influenza vaccine market in Norway is expected to reach a projected revenue of US$ 24.9 million by 2030. A compound annual growth rate of 7.1% is expected of Norway influenza vaccine market from 2024 to 2030.

Pharmaceuticals
- Vaccines
  - Influenza Vaccine Market Outlook

Norway influenza vaccine vaccine type outlook (Revenue, USD million, 2018-2030)
- Inactivated
- Live Attenuated
Norway influenza vaccine indication outlook (Revenue, USD million, 2018-2030)
- Quadrivalent
- Trivalent
Norway influenza vaccine age group outlook (Revenue, USD million, 2018-2030)
- Pediatric
- Adult
Norway influenza vaccine route of administration outlook (Revenue, USD million, 2018-2030)
- Injection
- Nasal Spray
Norway influenza vaccine distribution channel outlook (Revenue, USD million, 2018-2030)
- Hospitals & Pharmacy
- Government & Institutional supply
- Other Distribution Channels

Norway Influenza Vaccine Market Size & Outlook, 2024-2030

Data Tree

Sign up - it's easy, and free!